1. Market Research
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Asia Pacific Allergy Immunotherapies Market to 2027- COVID-19 Impact and Regional Analysis - By Treatment, Allergy Type, Distribution Channel, and Geography

Asia Pacific Allergy Immunotherapies Market to 2027- COVID-19 Impact and Regional Analysis - By Treatment, Allergy Type, Distribution Channel, and Geography

  • September 2020
  • 115 pages
  • ID: 5978814
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Jun 20th 2021


Table of Contents

Search Inside

The Asia Pacific allergy immunotherapies market was valued at US$ 697.5 million in 2019 and is projected to reach US$ 871.08 million by 2027; it is expected to grow at a CAGR of 11.5 % during the forecast period.

The Asia Pacific allergy immunotherapies market is expected to witness substantial growth during the forecast period owing to increasing incidence of chronic diseases, rising disposable income of individuals and improving conditions of healthcare infrastructure. However, drawbacks associated with the use of allergy immunotherapies and variations in regulatory framework across different countries in the region hamper the growth of the market.

Allergy immunotherapy is primarily aimed at reducing symptoms and symptomatic medication usage, and improving allergy-related quality of life.The allergy immunotherapy market in Asia Pacific is expected to exhibit the highest CAGR among all major regional markets due to the increased incidence of allergy in developing Asian countries such as China and India.

In Asia Pacific countries, ~20–30% of the total population has more than one type of allergy.Efforts toward establishing excellent regulatory scenario for the sale of drugs through online pharmacies would boost the allergy immunotherapy business growth and development in Asia Pacific in the coming years.

The growing unmet needs of novel targeted drugs used to treat the allergic conditions act as key opportunities for the growth of market players.Many companies are investing in research and development to develop targeted drugs for various allergic disorders.

The introduction of more such allergen immunotherapy tablets (AITs) in potential segments helps them expand their share in the global marketplace.

The COVID-19 pandemic has harmed the Asia Pacific allergy immunotherapies market size, with small and medium-scale companies struggling to sustain their businesses in the near future. Industry leaders are now focusing on creating new business practices to deal with such crises.

The Asia Pacific allergy immunotherapies market, based on Treatment, is segmented into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).In 2019, the SCIT segment held a larger share of the market.

However, the SLIT segment is expected to grow at a higher CAGR during the forecast period.The Asia Pacific allergy immunotherapies market, based on allergy type, is segmented into allergic rhinitis, asthma, food allergy, venom allergy, and others.

The allergic rhinitis segment held the greatest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during 2020–2027.
The Asia Pacific allergy immunotherapies market, based on distribution channel, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. In 2019, the hospital pharmacy settings segment held the largest share of the market, and market for the same segment is expected to grow at the fastest CAGR during the forecast period.

A few of the major primary and secondary sources associated with the Asia Pacific allergy immunotherapy market report are Celsion Corporation, World Allergy Organization (WAO), Asia Pacific Association of Allergy and Asthma and Clinical Immunology (APAACI).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

South and Central America Amniotic Membrane Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Enzyme ; Application; End User,and Country

  • $ 3000
  • November 2020
  • 111 pages

The South and Central America Amniotic Membrane market is expected to reach US$ 85.3 million by 2027 from US$ 55.6 million in 2019. The market is estimated to grow with a CAGR of 5.7% from 2020 to 2027. ...

  • Central America
  • Allergy Immunotherapy
  • Industry analysis
  • Allergy Prevalence
  • Drug Approval


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on